145 related articles for article (PubMed ID: 32117639)
1. Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma.
Wang G; Zhong Y; Liang J; Li Z; Ye Y
PeerJ; 2020; 8():e8625. PubMed ID: 32117639
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase M2 is a marker of poor prognosis in lung adenocarcinoma but not lung squamous cell carcinoma.
Zhang J; Zhang C; Liu X; Sun N; Zhang C; Li R; Zhang Z
Transl Cancer Res; 2020 May; 9(5):3293-3302. PubMed ID: 35117696
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
Guo CY; Zhu Q; Tou FF; Wen XM; Kuang YK; Hu H
BMC Cancer; 2019 Mar; 19(1):289. PubMed ID: 30925904
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma.
Li H; Guo H; Huang Q; Wang S; Li X; Qiu M
Respir Res; 2023 Oct; 24(1):252. PubMed ID: 37880717
[TBL] [Abstract][Full Text] [Related]
5. PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer.
Yin L; Shi J; Zhang J; Lin X; Jiang W; Zhu Y; Song Y; Lu Y; Ma Y
Sci Rep; 2023 Dec; 13(1):22243. PubMed ID: 38097666
[TBL] [Abstract][Full Text] [Related]
6. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
Chen S; Lu Z; Chen X; Wu X; Tu H; Yu L; Xiao Z
Oncol Lett; 2020 Nov; 20(5):147. PubMed ID: 32934715
[TBL] [Abstract][Full Text] [Related]
7. Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis.
Huang C; Huang Z; Bai P; Luo G; Zhao X; Wang X
Onco Targets Ther; 2018; 11():2075-2082. PubMed ID: 29695915
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of AURKB gene in lung adenocarcinoma: Analysis based on the data-mining of bioinformatic database.
Gao X; Jiang A; Shen Y; Lu H; Chen R
Medicine (Baltimore); 2021 Aug; 100(31):e26439. PubMed ID: 34397793
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer.
Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Aug; 18(30):4037-43. PubMed ID: 22912555
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of pyruvate kinase M2 expression in esophageal squamous cell carcinoma and its meta-analysis.
Zhang Q; Zheng S; Liu Q; Liu T; Tuerxun A; Yang L; Han X; Lu X
Transl Cancer Res; 2021 Jun; 10(6):2643-2652. PubMed ID: 35116577
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
15. SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
Liu G; Li F; Chen M; Luo Y; Dai Y; Hou P
Front Genet; 2022; 13():813285. PubMed ID: 35356432
[No Abstract] [Full Text] [Related]
16. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
17. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
18. GRSF1 predicts an unfavorable prognosis and promotes tumorigenesis in lung adenocarcinoma based on bioinformatics analysis and
Huang R; Xu L; Chen Q; Tuersuntuoheti A; Su L; Xu F; Bi Y; Deng Y; Song W; Zhao H; Che X
Ann Transl Med; 2022 Jul; 10(13):747. PubMed ID: 35957724
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
Wu J; Hu L; Chen M; Cao W; Chen H; He T
Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
Zhu H; Luo H; Zhu X; Hu X; Zheng L; Zhu X
Oncotarget; 2017 Jan; 8(1):1628-1640. PubMed ID: 27911861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
